Nav1.8-IN-16
Nav1.8-IN-16 (Compound (R) -40) is an orally active and selective hNaV 1.8 inhibitor (IC50: 5.9 nM) . Nav1.8-IN-16 exerts analgesic effects by blocking NaV1.8 channels without significantly affecting other NaV subtypes or hERG channels. Nav1.8-IN-16 exhibits dose-dependent analgesic effects in postoperative pain and inflammatory pain models and can be used in pain-related research[1].
Product Specifications
UNSPSC
12352005
Target
Sodium Channel
Related Pathways
Membrane Transporter/Ion Channel
Field of Research
Inflammation/Immunology; Neurological Disease
Smiles
O=C(NC1=CC=C(F)C(C(N)=O)=C1)C2=CC(Cl)=C(C(F)(F)F)C=C2[C@H]3CCOC4=C3C=CC=C4F
Molecular Formula
C24H16ClF5N2O3
Molecular Weight
510.84
References & Citations
[1]Li N, et al. Conformational restriction enables discovering a series of chroman derivatives as potent and selective NaV1.8 inhibitors with improved pharmacokinetic properties. Eur J Med Chem. 2025 May 6;293:117697.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Nav1.8
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LC400350 20 µg
Retinoic Acid Receptor alpha (RARA) (NM_000964) Human Over-expression Lysate
Sign In for Pricing
View Details 